Excretion and metabolism of propionyl-L-carnitine in the isolated perfused rat kidney

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1071-1076

  Evans, Allan M ^a   Mancinelli, Angelo ^b   Longo, Antonio ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b Sigma Tau SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; PROPIONYLCARNITINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; GLOMERULUS FILTRATION; KIDNEY PERFUSION; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARNITINE; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030925428     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. BAHL, J. J. AND BRESSLER, R.: The pharmacology of carnitine. Annu. Rev. Pharmacol. Toxicol. 27: 257-277, 1987.
2. BARTELS, G. L., REMME, W. J., PILLAY, M., SCHONFELD, D. H., Cox, P. H., KRUIJSSEN, H. A. AND KNUFMAN, N. M.: Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans. J. Cardiovasc. Pharmacol. 20: 157-164, 1992.
3. 4-acetyl metabolite by the isolated perfused rat kidney. Drug Metab. Dispos. 12: 607-613, 1984.
4. BERNARDINI, I., RIZZO, W. B., DALAKAS, M., BERNAR, J. AND GAHAL, W. A.: Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J. Clin. Invest. 75: 1124-1130, 1985.
5. BIEBER, L. L.: Carnitine. Annu. Rev. Biochem. 57: 261-283, 1988.
6. BREMER, J.: Carnitine: metabolism and functions. Physiol. Rev. 63: 1420-1479, 1983.
7. BREVETTI, G., PERNA. S., SABBÀ, C., ROSSINI, A., SCOTTO D. I. UCCIO, V., BERARDI, E. AND GODI, L.: Superiority of L-propionyl-carnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease. An acute, intravenous, double-blind, crossover study. Eur. Heart J. 13: 251-255, 1992.
8. ENGEL, A. G., REBOUCHE, C. J., WILSON, D. M., GLASCOW, A. M., ROMSHE, C. A. AND CRUSE, R. P.: Primary systemic carnitine deficiency. II. Renal handling of carnitine. Neurology 31: 819-825, 1981.
9. GAHL, W. A.. BERNARDINI, I., DALAKAS, M., RIZZO, W. B., HARPER, G. S., HOEG, J. M., HURKO, O. AND BERNAR, J.: Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome. J. Clin. Invest. 81: 549-560, 1988.
10. GOA, K. L. AND BROGDEN, R. N.: 1-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic heart disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs 34: 1-24, 1987.
11. GRECO, A. V. AND MINGRONE, G.: Effect of propionyl-L-carnitine in the treatment of diabetic angiopathy. Controlled double blind trial vs placebo. Drugs Exp Clin. Res. 18: 69-80, 1992.
12. GROSS, C. J. AND HENDERSON, L. M.: Absorption of D-and L-carnitine by the intestine and kidney tubule in the rat. Biochim. Biophys. Acta 772: 209-219, 1984.
13. HARPER, P., ELWIN, C. E. AND CEDKRBLAD, G.: Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects. Eur. J. Clin. Pharmacol. 35: 69-75, 1988.
14. HOKLAND, B. M. AND BREMER, J.: Metabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney. Biochim. Biophys. Acta 886: 223-230, 1986.
15. HOPPEL L. C.: Determination of carnitine. In Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual, ed. by F. A. Hommess, pp. 309-326, Wiley-Liss, New York, 1991.
16. MANCINELLI, A., LONGO, A., SHANAHAN, K. AND EVANS A. M.: Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney J. Pharmacol. Exp. Ther. 274: 1122-1128, 1995.
17. MARZO, A., ARRIGONI-MARTELLI, E., URSO, R., ROCCHETTI, M., RIZZA, V. AND KELLY, J. G.: Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers. Eur. J. Clin. Pharmacol. 37: 59-63, 1989.
18. MILLINGTON, D. S., NORWOOD, D. L., KODO, N., ROE, C. R. AND INOUE F.: Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood and tissue. Anal. Biochem. 180: 331-339, 1989.
19. MINKLER, P. E. AND HOPPEL L. C.: Quantification of free carnitine, individual short-and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography. Anal. Biochem. 212: 510-518, 1993.
20. PAULSON, D. J., TRAXLER, J. S., SCHMIDT, M. L., NOONAN, J. J. AND SHUG, A. L.: Protection of ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc. Res. 20: 536-541, 1986.
21. REBOUCHE, C. J. AND ENGEL, A. G.: Significance of renal γ-butyrobetaine hydroxylase for carnitine biosynthesis in man. J. Biol. Chem. 255: 8700-8705, 1980.
22. REBOUCHE, C. J. AND PAULSON, D. J.: Carnitine metabolism and function in humans. Annu. Rev. Nutr. 6: 41-66, 1986.
23. REBOUCHE, C. J., LOMBARD, K. A. AND CHENARD, C. A.: Renal adaptation to dietary carnitine in humans. Am. J. Clin. Nutr. 58: 660-665, 1993.
24. REBOUCHE, C. J. AND MACK, D. L.: Sodium gradient-stimulated transport of L-carnitine into renal brush border membrane vesicles: kinetics, specificity, and regulation by dietary carnitine. Arch. Biochem. Biophys. 235: 393-402, 1984.
25. SILIPRANDI, D., DI LISA, F., PIVETTA, A., MIOTTO, G. AND SILIPRANDI, N.: Transport and function of L-carnitine and L-propionylcarnitine relevance to some cardiomyopathies and cardiac ischaemia. Z. Kardiol. 76: suppl. 5, 34-40, 1987.
26. SILIPRANDI, N., DI LISA, F. AND MENABÒ, R.: Propionyl-L-carnitine: Biochemical significance and possible role in cardiac metabolism. Cardiovasc. Drugs Ther. 5: suppl. 1, 11-15, 1991.
27. SMITH, D. E. AND KUGLER, A. R.: Influence of intrarenal metabolism on the analysis of renal drug transport mechanisms. J. Pharm. Sci. 83: 1519-1520, 1994.
28. STEINMANN, B., BACHMANN, C., COLOMBO, J. P. AND GITZELMAN, R.: The renal handling of carnitine in patients with selective tubulopathy and with Fanconi syndrome. Pediatr. Res. 21: 201-204, 1987.
29. VARY, T. C. AND NEELY, J. R.: Sodium dependence of carnitine transport in isolated perfused rat hearts. Am. J. Physiol. 244: H247-H252, 1983.
30. VON LEHMANN, B., WAN, S. H., RIEGELMAN, S. AND BECKER, C.: Renal contribution to overall metabolism of drugs IV: biotransformation of salicylic acid to salicyluric acid in man. J. Pharm. Sci. 61: 1284-1287, 1973.
31. WAN, S. H. AND RIEGELMAN, S.: Renal contribution to overall metabolism of drugs. I: Conversion of benzoic acid to hippuric acid. J. Pharm. Sci. 61: 1278-1284, 1972a.
32. WAN, S. H. AND RIEGELMAN, S.: Renal contribution to overall metabolism of drugs. II: Biotransformation of salicylic acid to salicyluric acid. J. Pharm. Sci. 61: 1284-1287, 1972b.